The Role of Fluorodeoxyglucose, 18F-Dihydroxyphenylalanine, 18F-Choline, and 18F-Fluoride in Bone Imaging with Emphasis on Prostate and Breast
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 36 (1) , 73-92
- https://doi.org/10.1053/j.semnuclmed.2005.09.002
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Positron emission tomography and bone metastasesSeminars in Nuclear Medicine, 2005
- Metastasis to bone: causes, consequences and therapeutic opportunitiesNature Reviews Cancer, 2002
- 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levelsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- The role of positron emission tomography in the management of bone metastasesCancer, 2000
- Analytical decision model for the cost-effective management of solitary pulmonary nodules.Journal of Clinical Oncology, 1998
- Skeletal metastases from breast cancer: uptake of 18 F-fluoride measured with positron emission tomography in correlation with CTSkeletal Radiology, 1998
- Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imagingNuclear Medicine and Biology, 1996
- Cost-effectiveness of PET imaging in clinical oncologyNuclear Medicine and Biology, 1996
- Positron emission tomographic measurement of bone marrow blood flow to the pelvis and lumbar vertebrae in young normal adults [published erratum appears in Blood 1994 Nov 15;84(10):3602]Blood, 1994
- Skeletal scanning in neoplastic diseaseCancer, 1976